Jason is a neuropharmacologist and life sciences business development executive with broad experience in technology innovation, neurology/psychiatry R&D, company creation and licensing. He is President & CEO and co-founder of Tellus. As Head of Neurosciences Business Development at GlaxoSmithKline he set the BD strategy, led licensing and M&A activities and facilitated relationships with alliance partners. Jason led the Technology Innovation team at Wake Forest Baptist Medical Center, working with research and clinical investigators to identify, patent, develop and commercialize therapeutics, medical devices and healthcare IT solutions. He led business development and scientific licensing activities at Opexa Therapeutics, UCB Pharma and Schwarz Biosciences and founded Innervate BD Solutions, a CNS technology and business advisory firm, in 2015. Jason holds a PhD in pharmacology from the University of North Carolina at Chapel Hill with post-doc training at the University of Zurich.